Tumor vessel density (CD-31), and cell proliferation (Ki-67) were significantly higher (2–4 fold, P < 0.05) in tumors that progressed from the treatment than in responsive tumors (Fig 1C), suggesting that the progressive tumors were able to resume angiogenesis and thereby tumor regrowth. This evidence concerns the gene PECAM1 and neoplasm.